According to Zacks, “Vista Oil & Gas, S.A.B. de C.V. is engaged in the energy sector. It focuses on the identification, acquisition and development of oil and gas fields primarily in Mexico, Argentina, Brazil and Colombia. Vista Oil & Gas, S.A.B. de C.V. is based in Mexico. “
Shares of VIST opened at $7.40 on Friday. The company has a 50 day simple moving average of $5.57. Visterra has a 52-week low of $3.80 and a 52-week high of $11.03.
Several hedge funds and other institutional investors have recently bought and sold shares of VIST. Boston Partners acquired a new stake in Visterra during the 3rd quarter worth $5,067,000. Dean Capital Investments Management LLC purchased a new stake in Visterra in the third quarter valued at $341,000. Finally, FNY Investment Advisers LLC acquired a new position in Visterra in the third quarter valued at $27,000.
Visterra Company Profile
Visterra Inc is a United States-based biotechnology company. The Company uses its Atomic Interaction Network analysis to identify disease targets and design effective therapeutics. The Company’s technology is based on its Hierotope Platform, which identifies an area, or epitope, on the target protein, glycoprotein or glycan that is fundamental to its structure and function.
Further Reading: How to calculate the intrinsic value of a stock
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Visterra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Visterra and related companies with MarketBeat.com's FREE daily email newsletter.